Crossmark

Correction to: Well-preserved liver function enhances the clinical impact of curative-intent subsequent treatment during lenvatinib treatment for unresectable hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1007/s12328-023-01825-7

Published Online: 2023-07-01

Published Print: 2023-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kawamura, Yusuke https://orcid.org/0000-0001-6148-0042
Akuta, Norio

Shindoh, Junichi

Matsumura, Masaru

Okubo, Satoshi

Tominaga, Licht

Fujiyama, Shunichiro

Hosaka, Tetsuya

Saitoh, Satoshi

Sezaki, Hitomi

Suzuki, Fumitaka

Suzuki, Yoshiyuki

Ikeda, Kenji

Arase, Yasuji

Hashimoto, Masaji

Kozuka, Takuyo

Kumada, Hiromitsu
License Information

Text and Data Mining valid from 2023-07-01

Version of Record valid from 2023-07-01
More Information

Article History

First Online: 1 July 2023

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below